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Featured Application: Recombinant protein polymers, genetically engineered to incorporate an-
timicrobial peptides, demonstrate a therapeutic effect. These materials can be employed for the
development of antimicrobial and biocompatible surfaces/coatings produced by sustainable means.
Abstract: Antibacterial resistance is a major worldwide threat due to the increasing number of
infections caused by antibiotic-resistant bacteria with medical devices being a major source of these
infections. This suggests the need for new antimicrobial biomaterial designs able to withstand the
increasing pressure of antimicrobial resistance. Recombinant protein polymers (rPPs) are an emerging
class of nature-inspired biopolymers with unique chemical, physical and biological properties. These
polymers can be functionalized with antimicrobial molecules utilizing recombinant DNA technology
and then produced in microbial cell factories. In this work, we report the functionalization of rPBPs
based on elastin and silk-elastin with different antimicrobial peptides (AMPs). These polymers were
produced in Escherichia coli, successfully purified by employing non-chromatographic processes,
and used for the production of free-standing films. The antimicrobial activity of the materials
was evaluated against Gram-positive and Gram-negative bacteria, and results showed that the
polymers demonstrated antimicrobial activity, pointing out the potential of these biopolymers for the
development of new advanced antimicrobial materials.
Keywords: antimicrobial resistance; antimicrobial surfaces; antimicrobial films; recombinant protein
polymers; silk-elastin proteins; elastin-like recombinamers; antimicrobial peptides
1. Introduction
The development of antimicrobial materials is a rapidly growing field, particularly for
biomedical applications, demanding new versatile materials. The increasing number of
infections caused by resistant bacteria and the low pace of discovery of new and efficient
antibiotics necessitates new therapeutic approaches. Moreover, there is an increasing
interest in the development of local antimicrobial treatment systems due to improved
effectiveness and selectivity.
Natural structural proteins offer a wide range of properties with exceptional physical
properties that meet those of synthetic polymers, with additional benefits of enhanced
biocompatibility, low immunogenicity and higher degradability [1,2]. The unique physical
properties of structural proteins are inherently linked to their composition, relying on the
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specific folding of building blocks that hierarchically assemble into well-defined structures.
These building blocks have been used as design modules for the formulation of recombinant
protein polymers (rPPs) with unique properties [1,3]. Recombinant DNA technology
allows the biological synthesis of precisely defined rPPs with absolute control over size
and composition. This technology is very powerful, enabling the design of multifunctional
protein-based materials by fusing genes encoding for individual protein blocks, and even
functional modules, into a single large gene [4]. For instance, the structure of rPPs can
be genetically manipulated to incorporate the minimal consensus repeats of silk and
elastin into the same molecule [5,6] and to include bioactive domains such as antimicrobial
peptides (AMPs) [7–9]. The versatility of this approach allows custom design of the
structure of rPPs to obtain functional protein materials that can be processed into different
active materials such as coatings, films and fiber mats [7–13].
Due to the unique balance of mechanical properties, biocompatibility and thermosta-
bility, elastin-like polypeptides/recombinamers (ELPs/ELRs) and silk-elastin-like pro-
teins/recombinamers (SELPs/SELRs) have been widely studied for the development of
biotechnological applications [1,14,15]. ELRs are composed of repeating amino acid build-
ing blocks with a typical sequence of VPGXG (V—valine, P—proline, G—glycine, X is any
amino acid except for proline) [16], characterized by a reversible temperature-dependent
phase-transitional behavior [17,18]. SELPs are a group of copolymers consisting of alternate
amino acid repetitions of silk blocks with sequence GAGAGS (A—alanine and S—serine)
and elastin blocks, repeated in tandem [6]. These copolymers combine hard (silk) and soft
(elastin) domains and can spontaneously form hydrogen-bonded antiparallel β-sheets, with
the silk blocks imparting thermal and chemical stability and the elastin blocks reducing the
overall crystallinity of the system, increasing its flexibility and water solubility [5,19].
Antimicrobial peptides (AMPs) are promising alternatives to classical antibiotics due
to their broad antimicrobial activity and remarkable efficacy [20]. Expressed in almost
all living organisms and being part of the innate immune system, AMPs are usually
amphipathic short peptides (fewer than 100 amino acid residues), with a positive net
charge (+2 to +9) at physiological pH [21,22]. These natural molecules are particularly
interesting as therapeutic agents due to their high selectivity toward bacterial cells over
mammalian cells [23,24], and low probability to elicit bacterial resistance [25]. Although the
underlying mechanisms of action of AMPs are still under active study, it is widely accepted
that the basic principle involves the electrostatic interaction of the cationic AMPs with
negatively charged components of the bacterial cell membranes [20,26,27]. This electrostatic
interaction leads to binding and accumulation of AMPs on the surface of the membranes,
promoting membrane depolarization and permeabilization [28]. Several models have
been proposed to explain the antimicrobial effect of AMPs and their interaction with the
bacterial cell membrane. The most widely described models include the “barrel stave”
model, the “toroidal-pore” model and the “carpet” model—several reviews are available
on this subject [20–22,28–30].
Due to their broad antimicrobial activity, AMPs have been immobilized onto the
surface of materials to confer contact-killing antimicrobial activity [31–34]. Compared
with soluble AMPs, the antimicrobial performance of surface-immobilized AMPs is gen-
erally reduced due to limited conformational freedom [35,36]. This can be compensated
by increasing the density of immobilized AMPs or through introduction of flexible spac-
ers [32,35]. Nevertheless, evidence with AMP-functionalized surfaces (e.g., films and
coatings) indicates that the use of AMPs tethered into surfaces [37–41] or using geneti-
cally engineered fusion proteins for processing into films or coatings [8,10,12,42] results in
surfaces with contact-killing antimicrobial activity by disrupting the integrity of bacteria
membranes, resulting in the leakage of intracellular content. The cationic nature of the
AMPs probably displaces the divalent cations that maintain the structural integrity of the
negatively charged surface of the bacteria, disrupting its integrity; thus, this effect by itself
might be sufficient to generate a lethal outcome [43,44].
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Our research group is pioneering the formulation of antimicrobial ELR-based materials
by genetically engineering an ELR, comprising 200 repetitions of the VPAVG sequence
(A200), to include the DNA sequence of AMPs [8,12,45]. We have produced antimicrobial
ELR-based films through functionalization with the antimicrobial peptides ABP-CM4 [12],
a 35 amino acid peptide from the hemolymph of silkworm, and BMAP18 [8], an 18-amino
acid truncated variant of bovine myeloid antimicrobial peptide-28. A200 is characterized
by an acute thermal hysteresis behavior and the ability to self-assemble into spherical
nanoparticles at temperatures above 33 ◦C [46,47]; we explored this unique behavior for
the purification of recombinant hepcidin [45], a 25 amino acid human liver antimicrobial
peptide, and suggested its potential application as antimicrobial drug delivery platform.
The aim of this study was to investigate the potential of using both ELRs and
SELPs functionalized with AMPs for the development of new antimicrobial surfaces (e.g.,
films/coatings). Moreover, we also provide a comparison on the antimicrobial performance
of SELP- and ELR-based materials obtained while using water and formic acid as solvents
for processing. To achieve this, functional SELP hybrids were obtained by using SELP-59-
A [6] as a structural module and the antimicrobial peptides ABP-CM4, BMAP18, hepcidin
and Synoeca-MP, an antimicrobial peptide isolated from Synoeca surinama social wasp [48],
as antimicrobial functional modules. These AMPs were chosen due to their broad and po-
tent antimicrobial activity against different microorganisms [48–54]. While the mechanism
of action for Synoeca-MP remains to be elucidated, it has been proposed that ABP-CM4,
BMAP18 and hepcidin promote cell membrane depolarization, permeabilization and dis-
ruption [51,52,54,55]. SELP-59-A is a protein copolymer designed and synthesized by our
research group [6] consisting of nine tandem repetitions of S5E9, where S is the silk block
with sequence GAGAGS and E is the elastin block with sequence VPAVG. This recombinant
protein polymer demonstrated good mechanical properties and cytocompatibility, as well
as a high versatility of processing [5,56]. To expand the range of antimicrobial ELR-based
materials, we also describe the production of hybrid ELRs comprising A200 as a structural
module and hepcidin and Synoeca-MP as functional modules. Hexafluoroisopropanol [57]
and formic acid [8,12,13] are commonly used as solvents for rPP processing such as those
described here. Here, we explored the use of water as a “greener” and mild alternative
for solvent casting. All the recombinant protein materials were used for the production
of free-standing films by solvent casting using water and formic acid as solvents and
evaluated for their antimicrobial performance against Gram-negative and Gram-positive
bacteria following adapted ISO guidelines.
2. Materials and Methods
2.1. Preparation of Genetic Constructions
Genetic constructions were obtained by standard genetic engineering techniques
using DNA sequences optimized for Escherichia coli codon usage, following previously
described methodologies [45]. Briefly, for A200-based constructions, the genetic sequences
coding for AMPs were chemically synthesized with flanking NdeI and KpnI restriction
sites (Genscript) and cloned at the N-terminus of A200, previously cloned into a modified
pET25b(+) (Novagen) expression plasmid [46]. For the AMP-SELP constructions, the
genetic sequences for AMPs were chemically synthesized with flanking NdeI restriction
sites (Genscript) and cloned at the N-terminus of SELP-59-A, previously cloned into
a modified pET25b(+) (Novagen) expression plasmid, containing a poly-histidine tag
(6x His) [6]. All the genetic constructions (Tables S1 and S2), Synoeca-A200 (Syn-A200),
Synoeca-SELP (Syn-SELP), hepcidin-A200 (Hep-A200), hepcidin-SELP (Hep-SELP), ABP-
CM4-SELP (CM4-SELP) and BMAP18-SELP were confirmed by DNA sequencing (Eurofins).
The final expression plasmids were transformed into E. coli BL21(DE3) for recombinant
protein production.
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2.2. Protein Production and Purification
All proteins—Hep-A200, MW = 87.9 kDa; Syn-A200, MW = 86.8 kDa; Hep-SELP,
MW = 60.0 kDa; Syn-SELP, MW = 58.6 kDa; CM4-SELP, MW = 60.8 kDa; BMAP18-SELP,
MW = 59.2 kDa)—were expressed in E. coli BL21(DE3) by means of auto-induction [6].
Cell cultures were allowed to grow for 22 h at 37 ◦C and 200 rpm, with a volumetric ratio
of 1:4 in Terrific Broth (12 g tryptone, 24 g yeast extract, 5.04 g glycerol, 12.54 g K2HPO4,
2.31 g KH2PO4, per liter), supplemented with 2 g/L lactose for auto-induction (TBlac), and
100 mg/L ampicillin (AMP-SELP) or 50 mg/L kanamycin (AMP-A200).
After protein production, bacterial cells were collected by centrifugation, resuspended
in TE buffer solution (50 mM Tris-HCl + 1 mM EDTA at pH 8.0) and disrupted by sonication
using a Vibra cell™ 75043 ultrasonic liquid processor (Bioblock Scientific) with a 25 mm
diameter probe (3 s pulse on, 9 s pulse off, total sonication time: 10 min). The pH of
the crude cell lysate was adjusted to 3.5 with 1.6 M HCl to precipitate endogenous E.
coli contaminants [6,45] and removed by centrifugation at 11,500× g for 20 min at 4 ◦C.
Samples were kept at ice-cold temperature during the entire process. Purification of AMP-
A200 proteins (Hep-A200 and Syn-A200) was achieved by means of inverse transition
cycling (ITC) based on previously described methodologies [45,46]. Briefly, the AMP-
A200 proteins were subjected to three cycles of hot (37 ◦C) and cold (4 ◦C) incubation
(2 h at each temperature) and centrifugation steps (11,500× g for 20 min) in ultrapure
water (mQ; Milli-Q®, Millipore). AMP-SELP proteins were purified by ammonium sulfate
precipitation with 20% saturation followed by dialysis against mQ water (refer to [6] for
detailed description), using natural cellulose with a 12,000–14,000 Da molecular weight
cut-off (Medicell Membranes Ltd.). Protein production and purification was assessed
by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) on a 10%
acrylamide gel with 0.3 M copper chloride (CuCl2) staining. Purified polymer fractions
were freeze-dried (Christ Alpha 2-4 LD Plus from Bioblock Scientific) and stored at room
temperature prior to use.
2.3. Western Blot Analysis of AMP-SELP
Following 10% SDS-PAGE electrophoresis separation of pure solutions of AMP-SELP,
protein bands were transferred onto a nitrocellulose membrane at 100 V for 1 h. The
membrane was then blocked for 1 h with 5% non-fat dried milk in TBS-T buffer (50 mM Tris-
HCl, 150 mM NaCl, 0.05% Tween 20 at pH 8), washed with TBS-T and incubated overnight
with mouse monoclonal anti-polyHistidine antibody (Sigma-Aldrich) diluted 1:3000 in
the blocking solution. Following incubation with the primary antibody, membrane was
washed with TBS-T and incubated with goat anti-mouse IgG peroxidase (HRP) antibody
(Sigma-Aldrich) diluted 1:5000 in the blocking solution. Protein detection was assessed by
chemiluminescence using the ECL detection system (Merck Millipore) and a Chemi-Doc
XRS system (BioRad).
2.4. Preparation of Free-Standing Films
Films of AMP-A200 and AMP-SELP were prepared by solvent casting using double-
distilled water (ddH2O) or formic acid (98%–100%, Merck) as solvents. Pure lyophilized
protein was dissolved in the corresponding solvent at ice-cold temperature to concentra-
tions of 10% (w/v) for AMP-A200 and 3% (w/v) for AMP-SELP, and mixed until complete
dissolution was achieved. A volume of 100 µL of each protein solution was cast onto
polytetrafluoroethylene (PTFE, Teflon®) molds with 10 mm diameter and allowed to dry
at room temperature under extraction. After complete solvent evaporation, films were
gently peeled off from the molds. The AMP-SELP free-standing films were subjected to a
post-processing treatment with methanol-saturated air at room temperature for 48 h in a
desiccator to promote water insolubility [5] and air-dried at room temperature for at least
48 h before characterization.
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2.5. Structural Characterization of AMP-SELP Films
Structural changes induced by the methanol treatment in the AMP-SELP films were
assessed by attenuated total reflection Fourier-transform infrared (ATR-FTIR) spectroscopy
using a Perkin Elmer Spectrum Two™ spectrometer with a DTGS (deuterated triglycine sul-
fate) detector, coupled with a single reflection diamond UATR (universal attenuated total re-
flectance, Perkin Elmer). Spectra were collected in the range between 4000 and 600 cm−1, af-
ter 64 scans with a resolution of 4 cm−1 and automatic correction of atmospheric CO2/H2O.
Spectra analysis was conducted in the amide I band region (1600–1700 cm−1) by sec-
ond derivatization and Gaussian curve fitting using OriginPro 9.0 software (OriginLab,
Northampton, MA) [58]. For a reliable comparison between the secondary structure assign-
ment of the different samples, curve fitting was performed with the same set of parameters.
The contribution of each fitted component to the amide I band was estimated by integration
of the area under the curve and normalizing for the total area of amide I.
2.6. Evaluation of Antimicrobial Activity
The antimicrobial activity of the polymeric films was assessed by direct contact against
E. coli HB101 and S. aureus ATCC6538 using an adapted version of ISO 22196 [12]. Films
were sterilized by UV exposure for 30 min and transferred to sterile non-treated polystyrene
(PS) flat bottom 24 well plates. The surface of the films was inoculated with 50 µL of
bacterial cell suspension (1 × 106 CFUs/mL) and incubated for 120 min at 37 ◦C. After
incubation, 950 µL of sterile 0.87% NaCl solution was added and carefully agitated by
gently pipetting up and down 10 times, followed by plating 100 µL of serial diluted cell
suspensions on LB agar (10 g tryptone, 5 g yeast extract, 10 g NaCl, 15 g agar, per liter).
Cell suspensions inoculated in empty wells (without protein films) were used as negative
control for antibacterial activity. Antimicrobial assays were performed in triplicate at
different days with three replicates each. Results were expressed as lethality percentage (%
kill) calculated by the equation:
% kill =




Two-way analysis of variance (ANOVA) with Bonferroni’s post-test and 95% confi-
dence level was carried out with GraphPad Prism 6 software. Results were presented as
mean values ± standard deviation (SD), and p ≤ 0.05 was considered statistically signif-
icant. All experiments were performed in triplicate and repeated at least three times in
independent days.
3. Results and Discussion
3.1. Production and Purification of Recombinant AMP-A200 and AMP-SELP
All recombinant proteins (Hep-A200, Syn-A200, Hep-SELP, Syn-SELP, CM4-SELP and
BMAP18-SELP) were successfully produced in E. coli BL21(DE3) at high expression levels
(see Figures 1b and 2a for representative samples).
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the white arrow) was obtained after three complete cycles. MWM—molecular weight marker (Precision Plus Protein Un-
stained Standards from Bio-Rad) in kDa; 1—cycle one, cold supernatant; 2—cycle one, hot supernatant; 3—cycle two, cold 
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stained with 0.3 M CuCl2. 
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Figure 2. (a) Representative SDS-PAGE analysis of the purification process for BMAP18-SELP by 
salting out with ammonium sulfate at 20% saturation: MWM—molecular weight marker (GRS Un-
stained Protein Marker from Grisp) in kDa; 1—crude cell lysate after sonication; 2—supernatant 
after acidification at pH 3.5; 3—supernatant after salting out; 4—fraction of the precipitated sample 
after salting out; 5—dialyzed protein sample. Gel was stained with 0.3 M CuCl2. (b) Representative 
SDS-PAGE (image on the left) and Western blot (image on the right) analysis of pure BMAP18-SELP 
(6) with unstained SDS-PAGE standard molecular weight marker (MWM, in kDa; BioRad). 
Purification of the A200-based protein polymers was achieved by ITC, resulting in 
highly pure protein factions (Figure 1). After three heating/cooling cycles (Figure 1a), a 
pure protein fraction was obtained, as demonstrated by presence of a single band around 
100 kDa (lane 7, Figure 1b). 
Purification of AMP-SELP was achieved by a non-chromatographic method involv-
ing the use of ammonium sulfate at 20% saturation for the selective precipitation of SELP 
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Figure 2. (a) Representative SDS-PAGE analysis of the purification process for BMAP18-SELP by
s lt ng out with ammonium sulfate at 20% turati n: MWM—molecular weight marker (GRS
Unstained Protein Marker fr m Grisp) in kDa; 1—crude cell lysate after sonication; 2—supernatant
after acidification at pH 3.5; 3—supernatant after salting out; 4—fraction of the precipitated sample
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SDS-PAGE (image on the left) and Western blot (image on the right) analysis of pure BMAP18-SELP
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Purific tion of the A200-based protein polymers was achieved by ITC, resulting in
highly pure protein factions (Figure 1). After three heating/cooling cycles (Figure 1a), a
pure protein fraction was obtained, as d monstrated by presence of a single band around
100 kDa (lane 7, Figure 1b).
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Purification of AMP-SELP was achieved by a non-chromatographic method involving
the use of ammonium sulfate at 20% saturation for the selective precipitation of SELP [6].
Analysis of the electrophoretic pattern of purified BMAP18-SELP (used in Figure 2 as
representative sample) revealed the presence of two strong bands at approximately 60
and 80 kDa and some less intense bands at lower molecular weights (Figure 2a). Western
blot analysis using antibodies to the His tag revealed a similar band profile (Figure 2b),
characterized by a strong band corresponding to BMAP18-SELP and unknown lower
molecular weight protein bands. Overall, ammonium sulfate precipitation demonstrably
resulted in pure AMP-SELP fractions.
The same electrophoretic pattern and Western blot results were observed for the
remaining SELP-based constructions (Figure S1). The abnormal gel mobility to higher
molecular weights than expected is a consequence of the hydrophobic nature of the proteins
and has been previously observed for other recombinant protein polymers [6,45,46,59,60].
After purification and lyophilization, the lyophilized product was weighed, resulting in
volumetric productivities per liter of production of 50 mg/L for Hep-A200, 90 mg/L for
Syn-A200, 90 mg/L for Hep-SELP, 73 mg/L for Syn-SELP, 120 mg/L for CM4-SELP and
70 mg/L for BMAP18-SELP.
3.2. Secondary Structure Analysis of AMP-SELP Films
Maintenance of structural integrity is fundamental in the development of materials,
especially for applications that require contact with aqueous environments such as culture
media or body fluids. Due to the intrinsic thermal hysteresis behavior of A200, both
Hep-A200 and Syn-A200 films were stable over a wide range of temperatures without
the need of crosslinking agents to promote structure stabilization [12,13]. However, as-
cast SELP materials based on the SELP-59-A backbone are highly water soluble, limiting
their potential application. Nonetheless, this limitation can be surpassed by treatment
with methanol, leading to water insolubility by inducing a physical crosslinking through
the formation of hydrogen-bonded β-sheets [5,56]. In this study, the AMP-SELP films
were exposed to a methanol-saturated atmosphere for 48 h, and structural changes were
evaluated by ATR-FTIR spectroscopy. Secondary structure analysis was performed based
on the amide I region (1600 to 1700 cm−1), a sensitive spectral region used for protein
studies, which occurs mostly from C=O stretching vibrations [61–63]. For all samples, the
infrared spectrum of the non-treated films was characterized by a broad amide I absorption
band centered at approximately 1628 cm−1 with a pronounced shoulder around 1646 cm−1
(Figure S2), indicating the presence of β-sheets and a relevant contribution from random
coils, respectively [5]. After the methanol treatment, the amide I band was narrower
and shifted to approximately 1623 cm−1, indicating that major contributions arise from
β-structures and less from other secondary structures [5,58]. Since the broad amide I
band collected from spectra collected results from the overlapping components arising
from the various secondary structure elements [64], band-narrowing techniques such
as second derivative analysis are pivotal for a more detailed characterization of protein
conformation, thus providing the basis for the quantitative estimation of protein secondary
structure [65–67]. Quantitative secondary structure analysis of AMP-SELPs was performed
by second derivative analysis and curve fitting methods, with assignment of structural
conformations by reference to literature [58,63] (Table S3).
After the methanol treatment, the β-sheet content of all films demonstrated an overall
increase of more than 8% for films prepared with water and more than 3% for films prepared
with formic acid in relation to the untreated samples (Table 1). These results indicate that
methanol induced a molecular reorganization (Figure S2), leading to the formation of
additional hydrogen-bonded β-sheets that resulted in water insolubility.
Appl. Sci. 2021, 11, 5352 8 of 14
Table 1. Beta-structure content of AMP-SELP films, produced from water and formic acid solutions,
after and before methanol (MetOH) treatment. Results presented as fractional distribution of total
β-structure content determined by second derivative and Gaussian curve fitting.
Water Formic Acid
Sample Untreated MetOH-Treated Untreated MetOH-Treated
Hep-SELP 45.62% 54.91% 44.90% 48.48%
Syn-SELP 38.40% 54.56% 48.70% 51.86%
CM4-SELP 40.86% 49.75% 44.42% 55.68%
BMAP18-SELP 37.62% 55.02% 45.95% 52.7%
3.3. Antimicrobial Activity of AMP-ELR and AMP-SELP Films
The antimicrobial activity of Hep-A200, Syn-A200, Hep-SELP, Syn-SELP, CM4-SELP
and BMAP18-SELP films (produced from aqueous or formic acid solutions) was evaluated
against S. aureus ATCC6538 (Gram-positive) and E. coli HB101 (Gram-negative) by direct
contact after 120 min.
Analysis of antibacterial assays reveals that antimicrobial performance is highly de-
pendent on the structural (ELR or SELP) and functional (AMP) modules and less dependent
on the solvent used for film production, although films produced with formic acid display
slightly higher average % kill values. Overall, the AMP-A200 films demonstrated better
antimicrobial performance than the AMP-SELP films, independently of the solvent used
(Figure 3).
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Syn-SELP and Hep-SELP films produced using formic acid as solvent show average
lethality percentage (% kill) values for E. coli near 17%, whereas Syn-A200 and Hep-A200
films produced using the same solvent demonstrated average values of approximately
96% and 88%, respectively (Figure 3a, Table 2). This same trend is observed for CM4-
SELP and BMAP18-SELP compared to reference values obtained in previous works [8,12]
(Table 2). The SELP-based films produced from formic acid present values of % kill
around 35% and 60% for CM4-SELP and BMAP18-SELP, respectively, whereas this value
increases to 86% and 100% using A200 as a structural backbone (Table 2). The distinct
antimicrobial performance observed for AMP-A200 and AMP-SELP films is possibly
due to the different conformations adopted by the structural modules (SELP and ELR)
in the protein polymers. ELRs adopt a highly hydrated structure with conformational
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flexibility [68,69]. This flexibility favors the ability of the AMPs to interact with bacteria. In
contrast, the methanol-treated SELPs adopt a more rigid crystalline structure, characterized
by antiparallel hydrogen-bonded β-sheet structures (silk II-like) [5,70,71]. As the AMPs
are fused to the N-terminal of the SELP, that is, to the silk blocks, the conformational
flexibility of the AMPs is therefore restricted, limiting the ability of AMP moieties to contact
with bacteria.
Table 2. Percentage lethality (% kill) of the different protein polymer films after 2 h incubation at
37 ◦C with Escherichia coli and Staphylococcus aureus. Films were produced by solvent casting using
(a) water and (b) formic acid as solvents. Experiments were performed in triplicate in independent
days with three replicates each.
Sample % Kill (E. coli) % Kill (S. aureus) Reference
Hep-A200 (a) 69.9 ± 10.2 60.8 ± 23.5 This work
Hep-A200 (b) 87.7 ± 8.3 76.7 ± 13.7 This work
Syn-A200 (a) 85.9 ± 9.0 75.4 ± 25.4 This work
Syn-A200 (b) 95.9 ± 6.2 85.6 ± 8.2 This work
CM4-A200 (b) 86.5 ± 0.7 69.7 ± 4.5 [12]
BMAP18-A200 (b) 100.0 98.8 ± 2.0 [8]
Hep-SELP (a) 11.4 ± 5.5 33.9 ± 41.9 This work
Hep-SELP (b) 17.7 ± 6.1 65.9 ± 30.8 This work
Syn-SELP (a) 28.9 ± 4.9 29.3 ± 44.7 This work
Syn-SELP (b) 16.9 ± 5.8 30.3 ± 62.2 This work
CM4-SELP (a) 28.1 ± 6.8 10.7 ± 59.6 This work
CM4-SELP (b) 34.8 ± 8.9 30.1 ± 4.8 This work
BMAP18-SELP (a) 73.7 ± 4.2 41.5 ± 35.3 This work
BMAP18-SELP (b) 60.4 ± 14.4 48.4 ± 24.5 This work
Comparing the mean values of lethality percentage (% kill) against the tested bacteria,
best results were generally obtained against E. coli than against S. aureus (Figure 3). The
antibacterial assays against S. aureus demonstrated high standard deviation (SD) values,
which are a consequence of the ability of S. aureus to grow as planktonic aggregates [72],
thus reducing the direct contact with the films. This observation has been previously
reported in a similar direct contact assay using CM4-A200 films [12] and fiber mats [13].
Indeed, scanning electron microscopy micrographs clearly demonstrated the ability of S.
aureus to form aggregates reducing the contact of the overall microbial community with
the film surface [12]. Similarly, in the present study, the antimicrobial action of the films
was mediated by direct contact, in which cells must be available to contact with the film
surface. If cells are able to form aggregates, only those in contact with the film surface
are subjected to an antimicrobial effect, explaining the high variability of the assay. Still,
analysis of the mean values demonstrates that, overall, the AMP-ELR films demonstrate a
better antibacterial performance than AMP-SELP films.
In addition to the structural backbone (ERL or SELP), the antimicrobial activity was
also influenced by the type of AMP. Comparing the effect of the functional module in the
antibacterial activity of the AMP-SELP films against E. coli, best results were obtained with
BMAP18 with average % kill values greater than 60%, whereas the lowest antimicrobial
performance was observed for Hep-SELP with % kill values lower than 20% (Table 2). The
apparent low antimicrobial performance of Hep-SELP films may be due to the secondary
structure of hepcidin. Unlike Synoeca, CM4 and BMAP18, which show a linear α-helix
secondary structure in membrane-mimicking environments [48,73,74], hepcidin forms a
less flexible β-hairpin structure, with a central core cross-linked by four disulfide bonds [75]
that might intertwine with SELP β-sheets, compromising the peptide interaction with
bacteria membranes.
Regarding the assays performed with E. coli (Figure 3a), results revealed that, for the
confidence interval considered, all polymer films (except for Hep-SELP films prepared
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using water as solvent) are statistically significant, demonstrating the antimicrobial effect
of these films.
The antimicrobial activity observed for the fusion proteins is attributed to the func-
tional module (AMPs) and not to the structural module (A200 or SELP). Previously, we
have demonstrated that CM4-A200 displays potent antimicrobial activity against P. aerug-
inosa, reaching lethality percentage values of ca. 97% [12]. When compared with other
A200-based fusion proteins (BMP2-A200: bonemorphogenetic protein-2 linked with A200
and prosubtilisin-A200: prosubtilisin enzyme linked with A200) the antimicrobial activity
was found to be very low (ca. 20% for BMP2-A200) or even absent (proliferation of ca. 14%
for prosubtilisin-A200) [12]. These results indicated that the antimicrobial performance was
attributed to the AMP and not to the structural A200. In a similar way, the antimicrobial
activity of non-functionalized SELPs (SELP without AMPs) demonstrated to be statistically
non-significant compared with the control (Figure S3). Finally, the attribution of antimicro-
bial activity to the diffusion of eroded molecules is very unlikely as antimicrobial assays
utilizing the Kirby–Bauer test demonstrated the absence of inhibition halos (unpublished
data). We have previously demonstrated that CM4-A200 and BMAP18-A200 do not show
inhibition halos in disk diffusion assays (Kirby–Bauer test) but exert a strong antimicrobial
effect mediated by direct contact [8,12].
4. Conclusions
In this study, we report the fabrication of new antimicrobial protein-based polymers
with different structural backbones (structural module), namely SELP-59-A, a silk-elastin-
like protein able to form self-structured β-sheet structures, and A200, an elastin-like recom-
binamer characterized by a more flexible conformation. The protein polymers were geneti-
cally engineered to include functional modules consisting of the amino acid sequences for
antimicrobial peptides hepcidin, ABP-CM4 and BMAP18, as well as the recently isolated
Synoeca-MP (Table S6). All constructs were successfully produced in E. coli, purified by
simple non-chromatographic approaches and processed into free-standing films using
water and formic acid as solvents. No statistically significant differences were observed
in the antimicrobial activity of films produced with water or with formic acid, indicating
the feasibility of using a water as mild and “green” alternative to more harsh chemicals.
However, evaluation of the antimicrobial activity of the films indicates that the structural
backbone plays a central role in antimicrobial performance suggesting that AMPs should
be conformationally free to exert their antimicrobial effect. While the AMP-ELR films were
highly effective in exerting an antimicrobial effect against E. coli and S. aureus, we propose
that the more rigid structure of the AMP-SELP materials restricts the ability of the AMPs to
interact with bacterial cells and consequently results in a more limited performance. A strat-
egy to overcome this limitation could be through the inclusion of flexible glycine/serine
spacers in the genetic design to improve the conformational freedom of the AMPs [76,77],
thereby increasing their accessibility. Bagheri et al. [36] demonstrated that the presence of
flexible spacers and their length are determinant factors for antimicrobial activity since
the presence of the spacer can enable peptide insertion into the cell. On the other hand,
the antimicrobial activity of AMPs can be lost when immobilized on surfaces without the
presence of a spacer [38,78]. This supports our assumption that increased antibacterial
activity can be achieved by introducing flexible spacers in the genetic design. Nevertheless,
SELP-based antimicrobial biomaterials can be promising opportunity for novel materials,
as SELPs combine the elasticity, resilience and solubility of elastin with the mechanical
strength and versatility of processing of silk [5,79].
Analysis of antimicrobial results against S. aureus revealed a high variability because
of its ability to form cell aggregates thus reducing the contact with the antimicrobial surface.
This high variability could be reduced by lowering the number of cells in the inoculum,
so as to ensure that the majority of bacteria are placed in contact with the film surface. As
such, although the antimicrobial assays were performed based on ISO 22196, we suggest
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that results should be critically analyzed upon assessing the antimicrobial performance of
surfaces while using cells with the ability to grow in aggregates.
Overall, the findings of the present study represent an important contribution to-
wards the rational design of genetically engineered protein polymers functionalized with
antimicrobial peptides and provide cues for a next generation of antimicrobial materials.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/
10.3390/app11125352/s1, Figure S1: SDS-PAGE (a) and Western blot (b) analysis of pure BMAP18-
SELP (2), CM4-SELP (3) and Hep-SELP (4) using anti-polyHistidine antibodies and pure SELP (1)
as control. MWM–molecular weight marker (broad range unstained SDS-PAGE Standard from
Bio-Rad) in kDa.; Figure S2: Curve-fitted deconvoluted spectrum with band assignment for SELP-
based films. The bands filled in green represent contributions of β-structures. The narrowing of
the amide I band and the shift of the peak center to lower wavenumber after methanol treatment
indicates a greater contribution arising from β-sheets.; Figure S3. Antimicrobial activity of non-
functionalized SELP (SELP-59-A without AMPs) assessed by direct contact with the surface of
the films against E. coli and S. aureus. Cell suspensions inoculated in empty wells were used as
reference for 100% survival. No statistically significant differences were observed between SELP
films and the control, indicating the absence of antimicrobial activity; Table S1: List of genetic
constructions used in this work. Molecular weight was calculated with Expasy Compute pI/Mw tool
(https://web.expasy.org/compute_pi/; accessed on 30 October 2020); Table S2: Amino acid sequence
and size of antimicrobial peptides. Molecular weight was calculated with Expasy Compute pI/Mw
tool (https://web.expasy.org/compute_pi/; accessed on 30 October 2020); Table S3: Vibrational band
assignments used for conformational structure quantification (Hu et al., 2006; Machado et al., 2015;
Pereira et al., 2017); Table S4: Number of CFUs obtained in the antimicrobial assays of AMP-SELP and
AMP-A200 films against Escherichia coli. Experiments were performed in triplicate in independent
days (n = 1, n = 2 and n = 3) with three replicas each. Each value corresponds to the number of CFUs
obtained in a plate after a 1:20 dilution in sterile saline solution. Each set of three values correspond
to replicates. Letters in superscript correspond to the respective control in each independent day
(n). Values between brackets were excluded from statistical analysis due to high deviating values or
due to contamination; Table S5: Number of CFUs obtained in the antimicrobial assays of AMP-SELP
and AMP-A200 films against Staphylococcus aureus. Experiments were performed in triplicate in
independent days (n = 1, n = 2 and n = 3) with three replicas each. Each value corresponds to the
number of CFUs obtained in a plate after a 1:20 dilution in sterile saline solution. Each set of three
values corresponds to replicates. Letters in superscript correspond to the respective control in each
independent day (n). Values between brackets were excluded from statistical analysis due to high
deviating values or due to contamination; Table S6: Amino acid sequences of constructions. Genetic
constructions were obtained by standard genetic engineering techniques using DNA sequences
optimized for Escherichia coli codon usage. Genetic sequences coding for AMPs were cloned at the
N-terminus of A200 and SELP polymers and were chemically synthesized with flanking NdeI and
KpnI restriction sites (A200-based constructions) or with flanking NdeI restriction sites (SELP-based
constructions). The full amino acid sequences are presented below. The sequences coding for the
AMPs are in red color and emphasized in bold.
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